ArticleBMC pharmacology & toxicology2024

Comparative analysis of adverse events associated with CDK4/6 inhibitors based on FDA's adverse event reporting system: a case control pharmacovigilance study.

Wanlong Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.